Cargando…

Antiretroviral pre-exposure prophylaxis implementation in the United States: a work in progress

INTRODUCTION: After the initial approval of the use of tenofovir disoproxil fumarate-emtricitabine (TDF/FTC) by the US Food and Drug Administration in 2012 for anti-HIV pre-exposure prophylaxis (PrEP), uptake was initially limited, but more recent community surveys and expert opinion suggest wider a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mayer, Kenneth H, Hosek, Sybil, Cohen, Stephanie, Liu, Albert, Pickett, Jim, Warren, Mitchell, Krakower, Douglas, Grant, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2015
Materias:	PrEP Implementation Science: State-of-the-Art and Research Agenda
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509893/ https://www.ncbi.nlm.nih.gov/pubmed/26198345 http://dx.doi.org/10.7448/IAS.18.4.19980

Ejemplares similares

The promises and challenges of pre-exposure prophylaxis as part of the emerging paradigm of combination HIV prevention
por: Cáceres, Carlos F, et al.
Publicado: (2015)

Pre-exposure prophylaxis in Southern Africa: feasible or not?
por: Venter, Willem Daniel François, et al.
Publicado: (2015)

Beyond “getting drugs into bodies”: social science perspectives on pre-exposure prophylaxis for HIV
por: Auerbach, Judith D, et al.
Publicado: (2015)

HIV pre-exposure prophylaxis and health and community systems in the Global South: Thailand case study
por: Colby, Donn, et al.
Publicado: (2015)

Pre-exposure prophylaxis for men and transgender women who have sex with men in Brazil: opportunities and challenges
por: Veloso, Valdilea G, et al.
Publicado: (2015)

Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda
por: Ying, Roger, et al.
Publicado: (2015)

Translating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive justice and advocacy for access
por: Hankins, Catherine, et al.
Publicado: (2015)

PrEP implementation: moving from trials to policy and practice
por: Cáceres, Carlos F, et al.
Publicado: (2015)

PrEP Implementation Science: State-of-the-Art and Research Agenda
por: Cáceres, Carlos F, et al.
Publicado: (2015)

Rethinking HIV prevention to prepare for oral PrEP implementation for young African women
por: Celum, Connie L, et al.
Publicado: (2015)

Seasonal PrEP for partners of migrant miners in southern Mozambique: a highly focused PrEP intervention
por: Cremin, Ide, et al.
Publicado: (2015)

Pre-exposure prophylaxis use among female sex workers in Gulu city, Uganda: a community-based cross-sectional study
por: Bongomin, Felix, et al.
Publicado: (2023)

Intention to use PrEP among men who have sex with men and engage in chemsex: an international descriptive study
por: de Sousa, Álvaro Francisco Lopes, et al.
Publicado: (2023)

Rectal 1% Tenofovir Gel Use Associates with Altered Epidermal Protein Expression
por: Romas, Laura, et al.
Publicado: (2016)

Ecole d'été de probabilités de Saint-Flour XXXVIII
por: Jan, Yves Le
Publicado: (2008)

Whole person HIV services: a social science approach
por: Van Heerden, Alastair, et al.
Publicado: (2023)

HIV cure: an acceptability scientific agenda
por: Bonney, Evelyn Y., et al.
Publicado: (2023)

Top Questions in ID: Pre-exposure Prophylaxis for HIV
por: Krakower, Douglas S, et al.
Publicado: (2017)

The Fidelity of a Pharmacy-Based Oral HIV Pre-Exposure Prophylaxis Delivery Model in Kenya
por: Omollo, Victor, et al.
Publicado: (2023)

HIV Pre-exposure Prophylaxis Uptake and Continuation Among Key Populations in Cameroon: Lessons Learned From the CHAMP Program
por: Ndenkeh, Jackson Jr Nforbewing, et al.
Publicado: (2022)

High Rates of Pre-exposure Prophylaxis Eligibility and Associated HIV Incidence in a Population With a Generalized HIV Epidemic in Rakai, Uganda
por: Ssempijja, Victor, et al.
Publicado: (2022)

Potential role of dietary lipids in the prophylaxis of some clinical conditions
por: Bhagat, Urvashi, et al.
Publicado: (2015)

Prophylaxis of medial compartment gonarthrosis in varus knee – current state of knowledge
por: Fryzowicz, Anna, et al.
Publicado: (2016)

Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women
por: Kourtis, Athena P., et al.
Publicado: (2017)

HIV, Combination Antiretroviral Therapy, and Vascular Diseases in Men and Women
por: Kovacs, Laszlo, et al.
Publicado: (2022)

Differentiated Care Preferences of Stable Patients on Antiretroviral Therapy in Zambia: A Discrete Choice Experiment
por: Eshun-Wilson, Ingrid, et al.
Publicado: (2019)

The neonatal intensive parenting unit: an introduction
por: Hall, S L, et al.
Publicado: (2017)

Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological Outcomes
por: Moorhouse, Michelle, et al.
Publicado: (2019)

Relationship Between Time to Initiation of Antiretroviral Therapy and Treatment Outcomes: A Cohort Analysis of ART Eligible Adolescents in Zimbabwe
por: Vogt, Florian, et al.
Publicado: (2017)

A worldwide charter for all children with asthma
por: Szefler, Stanley J., et al.
Publicado: (2020)

Effect of Digital Adherence Tools on Adherence to Antiretroviral Treatment Among Adults Living With HIV in Kilimanjaro, Tanzania: A Randomized Controlled Trial
por: Sumari-de Boer, I. Marion, et al.
Publicado: (2021)

Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium
por: Kandzari, David E., et al.
Publicado: (2022)

Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding Risk
por: Urban, Philip, et al.
Publicado: (2019)

1523 Attitudes and Interest Toward HIV Pre-Exposure Prophylaxis Among Participants Using HIV Non-Occupational Post-Exposure Prophylaxis
por: Jain, Sachin, et al.
Publicado: (2014)

Pre-exposure prophylaxis for HIV prevention in women: current perspectives
por: Flash, Charlene A, et al.
Publicado: (2017)

Dynamics of Pre-Exposure (PrEP) Eligibility Because of Waxing and Waning of HIV Risk in Rakai, Uganda
por: Ssempijja, Victor, et al.
Publicado: (2023)

Oncogenic dysregulation of pre‐mRNA processing by protein kinases: challenges and therapeutic opportunities
por: Naro, Chiara, et al.
Publicado: (2021)

Emergent processes in cognitive-emotional interactions
por: Pessoa, Luiz
Publicado: (2010)

Bipolar disorder
por: Goodwin, Frederick K., et al.
Publicado: (1999)

Depression in late life
por: Barry, D. Lebowitz
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_gmihh4us6smcuru3j8f0gb28is